REFERENCES
1. Laste NJ, Harpster NK. A retrospective study of 100 cases of feline distal aortic thromboembolism: 1977-1993. J Am Anim Hosp Assoc 1995;31(6):492-500.
2. Smith SA, Tobias AH, Jacob KA, et al. Arterial thromboembolism in cats: acute crisis in 127 cases (1992-2001) and long-term
management with low-dose aspirin in 24 cases. J Vet Intern Med 2003;17(1):73-83.
3. Peterson EN, Moise NS, Brown CA, et al. Heterogeneity of hypertrophy in feline hypertrophic heart disease. J Vet Intern Med 1993;7(3):183-189.
4. Rush JE, Freeman LM, Fenollosa NK, et al. Population and survival characteristics of cats with hypertrophic cardiomyopathy:
260 cases (1990-1999). J Am Vet Med Assoc 2002;220(2):202-207.
5. Atkins CE, Gallo AM, Kurzman ID, et al. Risk factors, clinical signs, and survival in cats with a clinical diagnosis of idiopathic
hypertrophic cardiomyopathy: 74 cases (1985-1989). J Am Vet Med Assoc 1992;201(4):613-618.
6. Fox PR, Maron BJ, Basso C, et al. Spontaneously occurring arrhythmogenic right ventricular cardiomyopathy in the domestic
cat: a new animal model similar to the human disease. Circulation 2000;102(15):1863-1870.
7. Cote E, Harpster NK, Laste NJ, et al. Atrial fibrillation in cats: 50 cases (1979-2002). J Am Vet Med Assoc 2004;225(2):256-260.
8. Kittleson MD, Kienle RD. Thromboembolic disease. In: Small animal cardiovascular medicine. St. Louis, Mo: Mosby, 1998;540-547.
9. Smith SA, Tobias AH. Feline arterial thromboembolism: an update. Vet Clin North Am Small Anim Pract 2004;34(5):1245-1271.
10. Sykes JE. Ischemic neuromyopathy due to peripheral arterial embolization of an adenocarcinoma in a cat. J Feline Med Surg 2003;5(6):353-356.
11. Hogan DF, Dhaliwal RS, Sisson DD, et al. Paraneoplastic thrombocytosis-induced systemic thromboembolism in a cat. J Am Anim Hosp Assoc 1999;35(6):483-486.
12. Ibarrola P, German AJ, Stell AJ, et al. Appendicular arterial tumor embolization in two cats with pulmonary carcinoma. J Am Vet Med Assoc 2004;225(7):1065-1069, 1048-1069.
13. Schober KE, Maerz I. Doppler echocardiographic assessment of left atrial appendage flow velocities in normal cats. J Vet Cardiol 2005;7(1):15-25.
14. Schober KE, Maerz I. Assessment of left atrial appendage flow velocity and its relation to spontaneous echocardiographic contrast
in 89 cats with myocardial disease. J Vet Intern Med 2006;20(1):120-130.
15. Black IW. Spontaneous echo contrast: where there's smoke there's fire. Echocardiography 2000;17(4):373-382.
16. Bedard C, Lanevschi-Pietersma A, Dunn M. Evaluation of coagulation markers in the plasma of healthy cats and cats with asymptomatic
hypertrophic cardiomyopathy. Vet Clin Pathol 2007;36(2):167-172.
17. Stokol T, Brooks M, Rush JE, et al. Hypercoagulability in cats with cardiomyopathy. J Vet Intern Med 2008;22(3):546-552.
18. Ohta K, Gotoh F, Tomita M, et al. Animal species differences in erythrocyte aggregability. Am J Physiol 1992;262(4 Pt 2):H1009-H1012.
19. Helenski CA, Ross JN Jr. Platelet aggregation in feline cardiomyopathy. J Vet Intern Med 1987;1(1):24-28.
20. Watson T, Shantsila E, Lip GYH. Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited. Lancet 2009;373:155-166.
21. Krishnamoorthy S, Lim SH, Lip GY. Assessment of endothelial (dys)function in atrial fibrillation. Ann Med 2009;41(8):576-590.
22. Schaub RG, Meyers KM, Sande RD, et al. Inhibition of feline collateral vessel development following experimental thrombolic
occlusion. Circ Res 1976;39(5):736-743.
23. Schaub RG, Meyers KM, Sande RD. Serotonin as a factor in depression of collateral blood flow following experimental arterial
thrombosis. J Lab Clin Med 1977;90(4):645-653.
24. Schaub RG, Gates KA, Roberts RE. Effect of aspirin on collateral blood flow after experimental thrombosis of the feline aorta.
Am J Vet Res 1982;43(9):1647-1650.
25. McMicheal M, Moore RM. Ischemia-reperfusion injury pathophysiology, part I. J Vet Emerg Crit Care 2004;14(4):231-241.
26. Cauwels A. Nitric oxide in shock. Kidney Int 2007;72(5):557-565.
27. Seal JB, Gewertz BL. Vascular dysfunction in ischemia-reperfusion injury. Ann Vasc Surg 2005;19(4):572-584.
28. Aroch I, Keidar I, Himelstein A, et al. Diagnostic and prognostic value of serum creatine-kinase activity in ill cats: a retrospective
study of 601 cases. J Feline Med Surg 2010;12(6):466-475.
29. Wegner K, Robertson SA, Kollias-Baker C, et al. Pharmacokinetic and pharmacodynamic evaluation of intravenous hydromorphone
in cats. J Vet Pharmacol Ther 2004;27(5):329-336.
30. Robertson SA, Lascelles BD, Taylor PM, et al. PK-PD modeling of buprenorphine in cats: intravenous and oral transmucosal administration.
J Vet Pharmacol Ther 2005;28(5):453-460.
31. Lamont LA. Feline perioperative pain management. Vet Clin North Am Small Anim Pract 2002;32(4):747-763, v.
32. Robertson SA, Lascelles BDX, Taylor P. Effect of 0.1, 0.2, 0.4 and 0.8 mg/kg of IV butorphanol on thermal antinociception
in cats. Vet Anaesth Analg 2003;30:108.
33. DiBartola S. Disorders of potassium. In: Fluid, electrolyte, and acid-base disturbances. St. Louis, Mo: Elsevier Health; 2006.
34. Lunsford KV, Mackin AJ. Thromboembolic therapies in dogs and cats: an evidence-based approach. Vet Clin North Am Small Anim Pract 2007;37(3):579-609.
35. Kellerman DL, Lewis DC, Meyers NC, et al. Determination of a therapeutic heparin dosage in the cat. (abstr). J Vet Intern Med 1996;10:231.
36. Thompson MF, Scott-Moncrieff JC, Hogan DF. Thrombolytic therapy in dogs and cats. J Vet Emerg Crit Care 2001;11(2):111-121.
37. Moore KE, Morris N, Dhupa N, et al. Retrospective study of streptokinase administration in 46 cats with arterial thromboembolism.
J Vet Emerg Crit Care 2000;10(4):245-257.
38. Welch KM, Rozanski EA, Freeman LM, et al. Prospective evaluation of tissue plasminogen activator in 11 cats with arterial
thromboembolism. J Feline Med Surg 2010;12(2):122-128.
39. Koyama H, Matsumoto H, Fukushima RU, et al. Local inter-arterial administration of urokinase in the treatment of a feline
distal aortic thromboembolism. J Vet Med Sci 2010;72(9):1209-1211.
40. Reimer SB, Kittleson MD, Kyles AE. Use of rheolytic thrombectomy in the treatment of feline distal aortic thromboembolism.
J Vet Intern Med 2006;20(2):290-296.
41. Smith SA, Kraft SL, Lewis DC, et al. Pharmacodynamics of warfarin in cats. J Vet Pharmacol Ther 2000;23(6):339-344.
42. Smith CE, Rozanski EA, Freeman LM, et al. Use of low molecular weight heparin in cats: 57 cases (1999-2003). J Am Vet Med Assoc 2004;225(8):1237-1241.
43. Alwood AJ, Downend AB, Brooks MB, et al. Anticoagulant effects of low-molecular-weight heparins in healthy cats. J Vet Intern Med 2007;21(3):378-387.
44. Vargo CL, Taylor SM, Carr A, et al. The effect of a low molecular weight heparin on coagulation parameters in healthy cats.
Can J Vet Res 2009;73(2):132-136.
45. Clarke RJ, Mayo G, Price P, et al. Suppression of thromboxane A2 but not of systemic prostacyclin by controlled-release aspirin. N Engl J Med 1991;325(16):1137-1141.
46. Quinn MJ, Fitzgerald DJ. Ticlopidine and clopidogrel. Circulation 1999;100(15):1667-1672.
47. Hogan DF, Andrews DA, Talbott KK, et al. Evaluation of antiplatelet effects of ticlopidine in cats. Am J Vet Res 2004;65(3):327-332.
48. Hogan DF, Andrews DA, Green HW, et al. Antiplatelet effects and pharmacodynamics of clopidogrel in cats. J Am Vet Med Assoc 2004;225(9):1406-1411.
49. Hamel-Jolette A, Dunn M, Bedard C. Plateletworks: a screening assay for clopidogrel therapy monitoring in healthy cats. Can J Vet Res 2009;73(1):73-76.
|
Featuring Information from:
